Cargando…
Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on vaccine safety on AstraZeneca COVID-19 vaccine
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Saudi Medical Journal
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149695/ https://www.ncbi.nlm.nih.gov/pubmed/33896793 |
Ejemplares similares
-
COVAX Statement on WHO emergency use listing for AstraZeneca/Oxford COVID-19 vaccine
Publicado: (2021) -
COVAX Statement on WHO emergency use listing for AstraZeneca/Oxford COVID-19 vaccine
Publicado: (2021) -
Interim statement on covid-19 vaccine booster doses
Publicado: (2021) -
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)